Effect of Genital Herpes on Cervicovaginal HIV Shedding in Women Co-Infected with HIV AND HSV-2 in Tanzania

Long‐Term Impact of Acyclovir Suppressive Therapy on Genital and Plasma HIV RNA in Tanzanian Women: A Randomized Controlled Trial

(2010) Clare Tanton et al.   JOURNAL OF INFECTIOUS DISEASES

Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial

(2010) Jairam R Lingappa et al.   LANCET

Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2

(2010) C. Celum et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa

(2009) Sinéad Delany et al.   AIDS

Suppressive Acyclovir Therapy Reduces HIV Cervicovaginal Shedding in HIV- and HSV-2-Infected Women, Chiang Rai, Thailand

(2008) Eileen F Dunne et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Herpes Simplex Virus (HSV)–Suppressive Therapy Decreases Plasma and Genital HIV‐1 Levels in HSV‐2/HIV‐1 Coinfected Women: A Randomized, Placebo‐Controlled, Cross‐Over Trial

(2008) Jared M. Baeten et al.   JOURNAL OF INFECTIOUS DISEASES

A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers

(2008) F M Cowan et al.   SEXUALLY TRANSMITTED INFECTIONS